RCSB PDB - 3NCZ: X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor (original) (raw)
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 2, optimization for blood pressure reduction in spontaneously hypertensive rats.
[Ginn, J.D.](/search?q=citation.rcsb%5Fauthors:Ginn, J.D.), [Bosanac, T.](/search?q=citation.rcsb%5Fauthors:Bosanac, T.), [Chen, R.](/search?q=citation.rcsb%5Fauthors:Chen, R.), [Cywin, C.](/search?q=citation.rcsb%5Fauthors:Cywin, C.), [Hickey, E.](/search?q=citation.rcsb%5Fauthors:Hickey, E.), [Kashem, M.](/search?q=citation.rcsb%5Fauthors:Kashem, M.), [Kerr, S.](/search?q=citation.rcsb%5Fauthors:Kerr, S.), [Kugler, S.](/search?q=citation.rcsb%5Fauthors:Kugler, S.), [Li, X.](/search?q=citation.rcsb%5Fauthors:Li, X.), [Prokopowicz, A.](/search?q=citation.rcsb%5Fauthors:Prokopowicz, A.), [Schlyer, S.](/search?q=citation.rcsb%5Fauthors:Schlyer, S.), [Smith, J.D.](/search?q=citation.rcsb%5Fauthors:Smith, J.D.), [Turner, M.R.](/search?q=citation.rcsb%5Fauthors:Turner, M.R.), [Wu, F.](/search?q=citation.rcsb%5Fauthors:Wu, F.), [Young, E.R.](/search?q=citation.rcsb%5Fauthors:Young, E.R.)
(2010) Bioorg Med Chem Lett 20: 5153-5156
PubMed: 20678931 Search on PubMed
PubMed Abstract:
Phenylglycine substituted isoquinolones 1 and 2 have previously been described as potent dual ROCK1/ROCK2 inhibitors. Here we describe the further SAR of this series to improve metabolic stability and rat oral exposure. Piperidine analog 20 which demonstrates sustained blood pressure normalization in an SHR blood pressure reduction model was identified through this effort.
Organizational Affiliation:
Department of Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA. john.Ginn@boehringer-ingelheim.com